disruptive therapeutic solutions


Allele Biotechnology and Pharmaceuticals Inc.

Established in 1999 Allele Biotechnology has focused on developing and adapting cutting edge technology for clinical and therapeutic use. Over the years Allele’s has worked on biological advancements that have been at the forefront of molecular biology research, including RNA interference, Fluorescent Proteins, Induced Pluripotent Stem Cells (iPSCs), Genome Editing, and camelid derived Single Domain Antibodies. In 2015 Allele established a cGMP facility in San Diego to further the clinical development of iPSC based cell therapy.